| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$62 |
Quarterly Activities & Cashflow Report
|
29 Jul 2025 8:42AM |
$0.615 |
$0.270 |
fallen by
56.10%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Biome Australia Limited reported record quarterly revenue for Q3 FY24.
- Revenue growth was attributed to strong demand, new product launches, and expanded distribution.
- The company onboarded new wholesale customers and invested strategically in marketing.
- Operational focus included cost control, gross margin improvement, and cash position reinforcement.
- Biome Australia launched innovative products, contributing to growth.
- Investments were made in inventory and marketing to support future sales.
- Cashflow from operating activities was negatively impacted by higher inventory purchases.
- The company maintained a strong outlook for continued growth in future quarters.
- Biome Australia reaffirmed its commitment to shareholder value through further market penetration and product innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$89 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:41AM |
$0.370 |
$0.490 |
risen by
32.43%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma Ltd progressed clinical and commercial strategies for SPONTAN®, an orodispersible film for erectile dysfunction.
- The company prepared for a clinical trial in Australia, including investigator engagement and recruitment programs.
- Expansion of commercialisation strategy and partnerships were highlighted during the quarter.
- LTR Pharma continued regulatory, manufacturing, and intellectual property initiatives for SPONTAN®.
- Financial overview showed net operating cash outflows but a solid end-of-quarter cash balance.
- Company confirmed sufficient funds are available for the execution of near-term milestones.
- Appendix 4C included details about cash flows and expenditure breakdown for the quarter ending 31 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$24 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement
|
29 Jul 2025 8:40AM |
$0.006 |
$0.012 |
risen by
100%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- 1AI (Algorae Pharmaceuticals Limited) reported continued progress in AI-driven drug discovery and development projects.
- The company highlighted strategic partnerships and collaborations formed during the quarter to enhance research capabilities.
- Operational updates included advancements in the proprietary AI platform and research pipelines.
- The Appendix 4C Cash Flow Statement detailed receipts, payments, and net cash outflows for the period.
- Cash at the end of the period was reported, outlining the company's liquidity position.
- Risks, regulatory compliance, and future growth opportunities were discussed.
- Management provided commentary on business direction and upcoming objectives for the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WIA Gold Limited (WIA) ORDINARY FULLY PAID |
Materials |
$681 |
Quarterly Activities and Cashflow Report - June 2025
|
29 Jul 2025 8:40AM |
$0.285 |
$0.400 |
risen by
40.35%
|
|
WIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Substantial progress achieved at Kokoseb Gold Discovery in Namibia, including successful drilling and resource extension.
- Regional exploration programs continued with systematic sampling and drilling, yielding encouraging results.
- Assay results confirmed high-grade gold intersections, supporting the potential for resource expansion.
- The company maintains a disciplined financial approach, with clear reporting on expenditures and cash balance.
- Corporate activities included community engagement and maintaining strong local partnerships.
- Future plans focus on further drilling, resource definition, and advancing key project milestones.
- The quarterly report demonstrates WIA Gold Limited’s commitment to sustainable exploration and value creation for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$144 |
First Responder Program Advanced & Grant Milestone Achieved
|
29 Jul 2025 8:40AM |
$1.795 |
$1.550 |
fallen by
13.65%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- EMvision Medical Devices Limited achieved an advanced milestone in its First Responder Program.
- The company secured a grant milestone, providing additional funding for development.
- EMvision’s portable brain imaging device is designed for pre-hospital and first responder environments.
- The technology targets rapid diagnosis of stroke and brain injuries in emergency settings.
- Progress includes technical development, clinical validation, and stakeholder collaboration.
- Secured funding will support further research, development, and regulatory activities.
- The initiative aligns with health sector priorities and seeks to address unmet clinical needs.
- EMvision outlines ongoing commercialization and regulatory pathways for the device.
- The announcement highlights the technology’s potential to improve patient outcomes and system efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Powerhouse Ventures Limited (PVL) ORDINARY FULLY PAID |
Financials |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:40AM |
$0.090 |
$0.140 |
risen by
55.56%
|
|
PVL - Price-sensitive ASX Announcement
Full Release
Key Points
- PVL released its Quarterly Activities Report and Appendix 4C for the quarter ending 31 March 2023.
- Active management of investment portfolio and support for investee companies remained a focus.
- No new major investments were made during the quarter.
- Net cash outflow was primarily due to operating and corporate costs.
- Cash and cash equivalents were maintained at quarter-end.
- Ongoing monitoring and management of liquidity and operational expenses.
- Updates were provided on key portfolio companies and investment status.
- Future strategy remains focused on prudent cash management and shareholder value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freelancer Limited (FLN) ORDINARY FULLY PAID |
Industrials |
$52 |
1H25 Results Presentation
|
29 Jul 2025 8:39AM |
$0.280 |
$0.115 |
fallen by
58.93%
|
|
FLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Freelancer Limited presented its financial and operational results for 1H25, covering the half-year ending 31 December 2023.
- The company recorded improvements in profitability, with gross margins rising and operating costs being significantly reduced.
- Freelancer.com, Escrow.com, and Freightlancer remain the core business segments, each showing resilience despite difficult macroeconomic conditions.
- Investments in AI-driven product features and innovation are a key priority, with several new initiatives underway.
- The company is expanding its enterprise and government business, leveraging its platform to secure larger, high-value contracts.
- Cost-saving measures, including staff reductions and operational streamlining, contributed to improved EBITDA.
- Freelancer maintains a strong balance sheet, with no debt and a healthy cash position.
- Management remains focused on long-term growth opportunities, especially in international markets and new product offerings.
- The business is actively responding to global economic pressures through prudent financial management and strategic repositioning.
- The document includes forward-looking statements regarding continued investment in technology and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$204 |
Appendix 4C, FY25 Annual Results and Investor Call Schedule
|
29 Jul 2025 8:38AM |
$1.620 |
$3.270 |
risen by
101.85%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$607 |
Update - Notification of buy-back - FPR
|
29 Jul 2025 8:37AM |
$2.860 |
$2.840 |
fallen by
0.70%
|
|
| OMG Group Limited (OMG) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Asia Roadshow Investor Presentation
|
29 Jul 2025 8:37AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
| Pancontinental Energy NL (PCL) ORDINARY FULLY PAID |
Energy |
$75 |
PEL 87 Prospective Resources Upgrade
|
29 Jul 2025 8:36AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
PCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Pancontinental Energy NL announced an upgraded independent Prospective Resources assessment for PEL 87 offshore Namibia.
- The new assessment focuses on the Saturn Turbidite Complex, which is now estimated to have significantly increased oil resource potential.
- The upgrade follows new technical studies, seismic data analysis, and positive regional drilling results.
- The upgraded resource estimates provide further confirmation of PEL 87’s substantial oil exploration potential.
- Pancontinental continues active engagement with potential partners to progress exploration and possible drilling in PEL 87.
- The announcement is based on independent geological evaluations and recent developments in Namibia’s offshore hydrocarbon sector.
- The company highlights the importance of the Saturn Complex as a key prospective play within the licence.
- The upgraded estimates are not yet classified as reserves; they remain prospective resources pending further drilling and appraisal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$89 |
Proposed issue of securities - LTP
|
29 Jul 2025 8:36AM |
$0.370 |
$0.490 |
risen by
32.43%
|
|
| Wildcat Resources Limited (WC8) ORDINARY FULLY PAID |
Materials |
$463 |
TABBA TABBA PFS CONFIRMS POTENTIAL FOR LONG-LIFE MINE
|
29 Jul 2025 8:36AM |
$0.180 |
$0.335 |
risen by
86.11%
|
|
WC8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Tabba Tabba PFS confirms robust, long-life mining potential for Wildcat Resources Limited.
- Initial mine life of 14 years with further upside from exploration and resource expansion.
- Two-stage development: early DSO operation followed by spodumene concentrate processing.
- High-grade lithium resource with low impurities confirmed.
- PFS forecasts strong project economics with significant cash flows and returns.
- Strategic project location and infrastructure advantages.
- Wildcat Resources to progress rapidly toward production.
- Potential for further resource upgrades and increased mine life.
- Ongoing exploration programs to support resource growth.
- Commitment to environmental, social, and governance (ESG) standards throughout the project lifecycle.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Activities and Cashflow Report June 2025
|
29 Jul 2025 8:36AM |
$0.003 |
$0.069 |
risen by
2,660%
|
|
PRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced exploration activities at Northern Territory gold projects.
- Drilling conducted at key prospects with ongoing geophysical surveys.
- Progress reported on Tanami and Lake Mackay projects.
- Assessment of drilling results for potential resource upgrades.
- Prudent cash management and expenditure aligned with exploration plans.
- Maintained a strong balance sheet through the quarter.
- Joint venture activities and updates on tenement holdings discussed.
- Strategic focus for the upcoming quarters outlined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$257 |
Invitation to Nova Webinar Streamed Live from Estelle Site
|
29 Jul 2025 8:36AM |
$0.270 |
$0.560 |
risen by
107.41%
|
|
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$6,130 |
Quarterly Exploration Update
|
29 Jul 2025 8:34AM |
$9.060 |
$13.420 |
risen by
48.12%
|
|
CMM - Price-sensitive ASX Announcement
Full Release
Key Points
- 13% increase in MRE to 4.5 Moz at MGGP.
- Maiden underground MRE for Orion South.
- High-grade gold intercepts indicate potential for underground operations.
- Completion of 47,983 metres of drilling at MGGP.
- Acquisition of Ninghan Gold Project enhances future discovery prospects.
- Further drilling planned in FY26 to expand resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$71 |
Q4 FY25 Result Presentation
|
29 Jul 2025 8:33AM |
$0.435 |
$0.300 |
fallen by
31.03%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Record full-year revenues achieved in FY25.
- Recurring revenue base continued to grow, improving revenue visibility.
- Positive EBITDA reported, reflecting operational efficiency.
- Secured new customers and expanded relationships with existing healthcare providers.
- Launched new features and enhancements in the enterprise imaging platform.
- Successful global deployments and implementations completed.
- Ongoing investment in research and development to drive product innovation.
- Strategic partnerships and initiatives supported market expansion.
- Strong sales pipeline indicates continued future growth.
- Focus on delivering value to customers and driving long-term shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,183 |
Change of Director's Interest Notice - J Fowles
|
29 Jul 2025 8:33AM |
$1.900 |
$1.665 |
fallen by
12.37%
|
|
| Superloop Limited (SLC) ORDINARY FULLY PAID |
Communication Services |
$1,637 |
Full Year FY25 Results Release Date
|
29 Jul 2025 8:32AM |
$3.140 |
$3.180 |
risen by
1.27%
|
|
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$5,876 |
June 2025 Quarterly presentation
|
29 Jul 2025 8:32AM |
$2.600 |
$3.110 |
risen by
19.62%
|
|
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$257 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2025 8:31AM |
$0.270 |
$0.560 |
risen by
107.41%
|
|
NVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced feasibility studies and development at the Estelle Gold Project in Alaska.
- Continued resource definition and exploration drilling to expand and improve the project's gold resource base.
- Progressed permitting, environmental studies, and stakeholder engagement activities.
- Infrastructure improvements at the project site, including camp and access upgrades.
- Maintained a strong financial position with prudent cash management and reporting.
- Reported net cash outflows from operating and investing activities as outlined in the Appendix 5B.
- Focused on project de-risking and value creation for shareholders.
- Actively engaged with local communities and regulatory authorities to progress approvals.
- Outlined plans for continued drilling and studies in the upcoming quarters.
- Reaffirmed commitment to the advancement of the Estelle Gold Project as its core asset.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:31AM |
$0.073 |
$0.300 |
risen by
310.96%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C Cash Flow Report for Q3 FY2023 released
- BSA Limited focused on core service delivery, customer relationships, and cost management
- Positive operating cash flow reported for the quarter
- Details of cash and cash equivalents and related party payments provided
- Business developments and new contract wins highlighted
- Ongoing strategic initiatives to position BSA for growth discussed
- No financing or investing cash flows for the period
- BSA maintained strong liquidity position through disciplined cash management
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BCI Minerals Limited (BCI) ORDINARY FULLY PAID |
Materials |
$1,234 |
June 2025 Quarterly Update
|
29 Jul 2025 8:31AM |
$0.335 |
$0.420 |
risen by
25.37%
|
|
| Sequoia Financial Group Ltd (SEQ) ORDINARY FULLY PAID |
Financials |
$15 |
Resignation of Non-Executive Director - Charles Sweeney
|
29 Jul 2025 8:30AM |
$0.240 |
$0.125 |
fallen by
47.92%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$71 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 8:30AM |
$0.435 |
$0.300 |
fallen by
31.03%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Annual recurring revenue (ARR) continued to grow, driven by new and renewed contracts.
- Strong global customer activity with notable wins and deployments in the U.S., Asia Pacific, and Middle East.
- Increased adoption and expansion of Mach7's enterprise imaging platform in both new and existing customer sites.
- Positive net operating cash flow for the quarter, reflecting healthy customer receipts.
- Maintained a strong cash position and remained debt free at quarter end.
- Ongoing investments in research and development to enhance product offerings.
- Continued focus on scaling sales and marketing activities to capture new growth opportunities.
- Outlook remains positive with a robust pipeline and ongoing customer engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
